| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0093 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.002 | 1 |